Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krusius

Showing results (141-150 of 148) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 148 results.
Vox Sanguinis|January 6, 2009
Neonatal transfusionsH V New, S J Stanworth, C P Engelfriet, et al.
Vox Sanguinis|July 14, 2001
The use of the computer cross-matchC P Engelfreit, H W Reesink, T Krusius, et al.
Vox Sanguinis|March 14, 2007
Measures to prevent TRALIS Wendel, S Biagini, F Trigo, et al.
Vox Sanguinis|January 22, 2008
Occult hepatitis B infection in blood donorsH W Reesink, C P Engelfriet, G Henn, et al.
Vox Sanguinis|May 10, 2005
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003J Coste, H W Reesink, C P Engelfriet, et al.
Vox Sanguinis|January 30, 2008
Biobanks of blood from donors and recipients of blood productsH W Reesink, C P Engelfriet, C A Hyland, et al.
Vox Sanguinis|May 8, 2014
Prevention of transfusion-transmitted cytomegalovirus (CMV) infection: Standards of careL Lieberman, D V Devine, H W Reesink, et al.
Vox Sanguinis|April 24, 2012
Measures to prevent transfusion-related acute lung injury (TRALI)H W Reesink, J Lee, A Keller, et al.
Pageof 15

Showing results (141-150 of 148) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 148 results.
Vox Sanguinis|January 6, 2009
Neonatal transfusionsH V New, S J Stanworth, C P Engelfriet, et al.
Vox Sanguinis|July 14, 2001
The use of the computer cross-matchC P Engelfreit, H W Reesink, T Krusius, et al.
Vox Sanguinis|March 14, 2007
Measures to prevent TRALIS Wendel, S Biagini, F Trigo, et al.
Vox Sanguinis|January 22, 2008
Occult hepatitis B infection in blood donorsH W Reesink, C P Engelfriet, G Henn, et al.
Vox Sanguinis|May 10, 2005
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003J Coste, H W Reesink, C P Engelfriet, et al.
Vox Sanguinis|January 30, 2008
Biobanks of blood from donors and recipients of blood productsH W Reesink, C P Engelfriet, C A Hyland, et al.
Vox Sanguinis|May 8, 2014
Prevention of transfusion-transmitted cytomegalovirus (CMV) infection: Standards of careL Lieberman, D V Devine, H W Reesink, et al.
Vox Sanguinis|April 24, 2012
Measures to prevent transfusion-related acute lung injury (TRALI)H W Reesink, J Lee, A Keller, et al.
Pageof 15